Effect of Unani medicine on Thyroid disease

Effect of Barg-e-Sahajana on Hypothyroidism-A Randomized Single Blind Placebo Controlled Clinical Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/033181

Enrollment

Registered

2021-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

Intervention1: Barg-e-Sahjana: Powdered Leaves Of Sahjana will be given 3gm orally once a day for 45 days Control Intervention1: Placebo Capsule: wheat flour will be given 3gm orally once a day for 45

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either genders between the age of 20-60 years ï?· New cases of hypothyroidism ï?· Patient having the TSH range between 6- 20ÂµIU/ml (TSH Normal range 0.3-5.5 ÂµIU/ml)20 ï?· Patients who will give consent and able to do follow up.

Exclusion criteria

Exclusion criteria: Patients age below 20 and above 60 year ï?· Patient having the TSH range 20mIU/L ï?· All complicated case of hypothyroidism ï?· Recent thyroid surgery or receive radioactive iodine treatment within 6 months. ï?· Pregnancy and lactating women

Design outcomes

Primary

Measure	Time frame
TSHTimepoint: every 15th day till 45 days	—

Secondary

Measure	Time frame
not applicableTimepoint: not applicable	—

Countries

India

Contacts

Public ContactAnsari Shabnam Mohd Ashfaque

National Institute Of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026